Table 1.
THERAPY AND EXAMS UPON ADMISSION | Medical records with informationn (%) | |
Beta-agonist inhalers - n (%)Systemic corticosteroids - n (%)Systemic antibiotics - n (%) | 185 (80%)119 (52%)126 (55%) | 230 (100)230 (100)230 (100) |
Radiography with opacification - n (%)Positive blood cultures - n (%)*** | 118 (54%)03 (02%) | 217 (94)149 (65) |
Pulse oximetry - median (p25–p75) | 89% (87–93) | 195 (85) |
C-reactive protein*) - median (p25–p75)Leukocytes** - median (p25–p75) | 11 (5–27.25)11,100 (7,900–15,150) | 112 (49)149 (65) |
Clinical course characteristics during hospitalization | ||
ICU*** - n (%)Time in ICU*** - median (p25–p75)MV# - n (%)Time in MV# - median (p25–p75) | 39 (17%)4 days (3–6)16 (07%)3.5 days (2.25–5.75) | 230 (100)230 (100)230 (100)230 (100) |
Total time in O2## - median (p25–p75) | 4 days (2–6) | 230 (100) |
Hospitalization period - median (p25–p75) | 6 days (4–8) | 230 (100) |
Values in µg/dL; **peripheral leukocyte count in cells/mL; ***ICU = intensive care unit; #MV = mechanical ventilation; ##O2 = oxygen therapy.